School of Medicine
Showing 3,801-3,900 of 4,713 Results
-
Hua Shan
Professor of Pathology
BioDr. Shan specializes in providing blood transfusion and apheresis treatment to patients with diverse medical problems. She has been practicing transfusion medicine for over twenty five years. Dr. Shan currently serves as the Medical Director of Transfusion Service at Stanford Medical Center. Dr. Shan has also been leading research and education programs in the fields of transfusion safety, optimizing clinical blood transfusion practice and blood availability.
-
Lucy Shapiro
Virginia and D. K. Ludwig Professor, Emerita
Current Research and Scholarly InterestsA basic question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code. Our goal is to define these mechanisms using both molecular genetics and biochemistry.
-
Naima G. Sharaf
Assistant Professor of Biology and, by courtesy, of Structural Biology
Current Research and Scholarly InterestsResearch in the lab bridges biology, microbiology, and immunology to translate lipoprotein research into therapeutics
-
Paul Sharek MD, MPH
Professor of Pediatrics (Hospital Medicine) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsResearch interests centered on hospital based quality of care improvement, and in particular pediatric patient safety. Areas of recent interest include developing practical tools to more accurately identify adverse medical events and to establish national rates of these adverse events. Additional areas of interest focus on developing the processes and systems to decrease the frequency of adverse drug events and adverse medical events at Children's hospitals in North America
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. My practice includes a Lung Graft-versus-Host-Disease (GVHD) Clinic for patients with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a Lung GVHD Consortium comprising Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health, one studying the association of respiratory viruses with Lung GVHD and a second studying the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. Separately, I see patients with pulmonary complications of infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including "Long COVID". I also see patients in the intensive care unit (ICU). My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my graduate level education and postdoctoral training in engineering and bioinformatics. I strive to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
-
Rahul P Sharma, MBBS, FRACP
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Carla Shatz
Sapp Family Provostial Professor, The Catherine Holman Johnson Director of Stanford Bio-X and Professor of Biology and of Neurobiology
Current Research and Scholarly InterestsThe goal of research in the Shatz Laboratory is to discover how brain circuits are tuned up by experience during critical periods of development both before and after birth by elucidating cellular and molecular mechanisms that transform early fetal and neonatal brain circuits into mature connections. To discover mechanistic underpinnings of circuit tuning, the lab has conducted functional screens for genes regulated by neural activity and studied their function for vision, learning and memory.
-
Gary M. Shaw
NICU Nurses Professor and Professor (Research), by courtesy, of Epidemiology and Population Health and of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsPrimary research interests include 1) epidemiology of birth defects, 2) gene-environment approaches to perinatal outcomes, and 3) nutrition and reproductive outcomes.
-
Jonathan Shaw
Clinical Associate Professor, Medicine - Primary Care and Population Health
Clinical Associate Professor (By courtesy), Obstetrics & GynecologyCurrent Research and Scholarly InterestsPrimary care, psycho-social determinants of health & care, maternal-child health
-
Kate Shaw, MD MS
Associate Professor of Obstetrics and Gynecology
Current Research and Scholarly InterestsMy research interests include expanding access to and and improving patient experience with contraception and abortion care both domestically and globally. I am also interested in medical education and resilience among physicians and trainees.
-
Richard J. Shaw, M.D.
Professor of Psychiatry and Behavioral Sciences (Child & Adolescent Psychiatry) &, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPsychological issues in medically ill children.
Medical posttraumatic stress disorder.
Treatment adherence.
Transplant psychiatry.
Pediatric oncology.
Forensic psychiatry. -
Xinshu She
Clinical Associate Professor, Pediatrics
Clinical Associate Professor, Pediatrics - General PediatricsCurrent Research and Scholarly InterestsMy current interests include global mental health promotion in underserved pediatric populations, including refugee health in US-Mexico borders, minority mental health in the US, and parental mental health in low-middle-income countries. I am also interested in physician wellness and Diversity and Inclusion.
-
Kevin Shea
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics
BioKevin G. Shea, MD is an orthopaedic surgeon at Stanford University Medical Center and the Lucile Packard Children’s Hospital. Dr. Shea grew up in Montana and California, graduated from the UCLA School of Medicine, and completed his orthopaedic residency at the University of Utah School of Medicine. His advanced training includes pediatric orthopaedics at Rady Children’s Hospital in San Diego, AO Fellowship in Bern Switzerland with Drs. Ganz (Hip), Dr. Diego Fernandez (Trauma), and Dr. Hans Staubli (sports), and Ilizarov Training in Lecco, Italy. He was the AOSSM Traveling Sports Medicine Fellow in 2008, and practiced in Boise, ID prior to joining the Stanford Faculty. Dr. Shea is a founding member of the PRiSM Society (Pediatric Research in Sports Medicine), the ROCK (Research in OsteoChondritis of the Knee) Multi-center Study Group, and the SCORE prospective cohort registry for pediatric sports arthroscopy outcomes, complications. He is a member of the AAOS (American Academy of Orthopaedic Surgeons), POSNA (Pediatric Orthopaedic Society of North America) and the AOSSM (American Orthopedic Society for Sports Medicine). In addition, Dr. Shea has authored more than 240 scientific papers and book chapters.
-
Clifford Charles Sheckter
Assistant Professor of Surgery (Plastic and Reconstructive Surgery)
Masters Student in Health Policy, admitted Autumn 2022BioDr. Cliff Sheckter is a California native, growing up in the rural Eastern Sierra. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC (Keck) for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He fell in love with burn care while at USC/LA General Medical Center and completed his surgical training at Stanford. While in residency, he pursued a fellowship/postdoc in Health Systems Design at Stanford’s Clinical Excellence Research Center (CERC). He received additional training in Surgical Critical Care and Burn Surgery at the University of Washington.
Dr. Sheckter is a health services and health policy researcher. His work focuses on burn prevention, health economics in surgical care, and health equity outcomes in burn care. He has authored over 120 articles and numerous book chapters. His research has been published in JAMA, JAMA Network Open, JAMA Surgery, Annals of Surgery, Journal of Plastic & Reconstructive Surgery, Burns, and Journal of Burn Care & Research. His work has been featured in USA Today and the New York Times. He was the recipient of a career development award from the NIH and has funding from the Plastic Surgery Foundation. Dr. Sheckter was awarded the American Burn Association (ABA) Traveling Fellow for 2023 and has won top abstract at the ABA Annual Meeting multiple times. He is an active member of the ABA Burn Prevention and Research Committees.
Dr. Sheckter is one of a few surgeons double-board certified in Surgical Critical Care and Plastic & Reconstructive Surgery. He practices critical care medicine as an intensivist in the Stanford Surgical ICU. He is the Director of the Regional Burn Center at Santa Clara Valley Medical Center which is the only burn/trauma center for the San Francisco Bay Area. He performs scar reconstruction using surgical and laser techniques. -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Javaid I. Sheikh
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsMy research focuses on studying phenomenology, vulnerability factors, and psychiatric and medical comorbidity of panic disorder in old age, as well as treatment responses to medication in elders with panic disorder. I am presently involved in establishing and extending our preliminary finding that Late-Onset Panic Disorder (LOPD) (onset at or after age 55) is a phenomenologically distinct syndrome from Early-Onset Panic Disorder (EOPD).
-
Andrew A. Shelton, MD, FACS, FACRS
Clinical Professor, Surgery - General Surgery
Current Research and Scholarly InterestsMultimodality treatment of rectal cancer
Sphincter preserving procedures for rectal cancer
Laparoscopic colon and rectal surgery
Surgical education -
Christopher Timothy Shen
Adjunct Professor, Medicine - Surgery
Academic Staff - Hourly - CSL, SurgeryBioDr. Shen is the Director of Global Strategic Initiatives at Stanford Biodesign and founding U.S. Executive Director of the Singapore Stanford Biodesign Program. Chris is an Adjunct Professor of Medicine at Stanford University, responsible for teaching and mentoring international and Stanford-based faculty and students in medical technology innovation.
Dr. Shen is also a Managing Director at CBC Group, one of the largest Asia-based, healthcare investment firms. With headquarters in Singapore, CBC is committed to building innovative companies that improve the health and quality of human life. Chris has over 20 years of experience in medical device design and innovation, and is focused on investments in the biopharma and medtech sectors. Previously, Chris held senior investing positions at Qiming Venture Partners, Vertex Healthcare/Temasek, EW Health, and New Enterprise Associates. Chris started his medtech career as a Senior Design Engineer at Guidant Neurovascular, where he was the principal inventor on one of the earliest stentriever devices for ischemic stroke.
Chris received his Doctor of Medicine from the Stanford School of Medicine, his Master of Business Administration from Stanford Graduate School of Business, and a Master of Biomechanical Engineering from the Stanford School of Engineering. He received his Bachelor of Science in Biological Sciences from Stanford University.
Dr. Shen teaches the Global Biodesign course: Global Biodesign: Medical Technology in an International Context – a project-based course that exposes students to the challenges and opportunities of developing and implementing innovative medical technologies to help patients around the world. He has authored twelve patents in the fields of interventional neuroradiology and interventional cardiology. -
Jeanne Shen
Associate Professor of Pathology
Current Research and Scholarly InterestsGastrointestinal and pancreatobiliary pathology, with major emphasis on GI and pancreatic neoplasia, inflammatory bowel disease, biodesign innovation, and the application of machine learning to digital pathology.
-
Kang Shen
Vincent V.C. Woo Director, Wu Tsai Neurosciences Institute, Frank Lee and Carol Hall Professor and Professor of Biology and of Pathology
Current Research and Scholarly InterestsThe connectivity of a neuron (its unique constellation of synaptic inputs and outputs) is essential for its function. Neuronal connections are made with exquisite accuracy between specific types of neurons. How each neuron finds its synaptic partners has been a central question in developmental neurobiology. We utilize the relatively simple nervous system of nematode C. elegans, to search for molecules that can specify synaptic connections and understand the molecular mechanisms of synaptic as
-
Luyao Shen, MD
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsGU and Gyn clinical imaging
-
Sam Shen
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsEmergency Department process improvement
Digital Health
ED operations
ED innovations -
Yelizaveta Sher, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty, now a Division of Medical Psychiatry, at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as the Director of Psychiatric and Psychological Services for the Adult Cystic Fibrosis Clinic and Chief of Psychosomatic Medicine Clinic. She has published many articles and book chapters and edited several books related to her fields of interest and expertise.
-
Gavin Sherlock
Professor of Genetics
Current Research and Scholarly InterestsEvolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species
-
Seth Lawrence Sherman, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsMy research focuses on ways to augment tissue healing, improve human performance, and prevent musculoskeletal injuries. Approaching these challenges through parallel basic science and clinical pathways, our team works from the “bedside to the bench and back to the bedside”, identifying areas of clinical need to deliver evidence-based solutions for patients.
We collaborates with orthopaedic surgeons, non-surgical physicians, and researchers within bioengineering, human performance, and musculoskeletal imaging across the Stanford campus. The team is developing novel methods to accurately record human movement (including wearable technology, phone-based systems), rapid MRI imaging protocols, and exploring the use of biomarkers to track injury and recovery. This research builds on my earlier work, which utilized portable, inexpensive software for Microsoft Kinect to detect knee injury risk in youth athletes performing a drop vertical jump test. The team’s multifaceted goal is: 1) develop innovative methods to screen for injury risk (i.e. youth athlete non-contact ACL), 2) create targeted intervention programs to reduce risk, 3) enhance athletic performance; and 4) improve accuracy of return to play testing following injury/surgery (i.e. clinical evaluation, biomarkers, functional tests, imaging analysis for healing).
In the laboratory,our team investigates cellular and molecular deficiencies in tissue types including tendon, ligament, articular cartilage, and meniscus. By understanding aberrant pathways leading to tissue injury, they can identify innovative therapeutic targets for intervention. In collaboration with the Genetic Engineering and Synthetic Biology laboratories, Dr. Sherman’s research has explored the role of orthobiologic agents such as platelet rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for tissue healing in patella tendinopathy (the breakdown of collagen in a tendon). Our lab is also investigating the use of CBD for musculoskeletal applications as an alternative to commonly used local anesthetics and cortisone derivatives. In my earlier work, we researched the cellular toxicity of such applications.
In addition to basic science research, I have helped to build a Sports Medicine clinical research team that includes several full-time clinical research coordinators, residents, fellows, and students. The team collects prospective outcomes on their patients using a novel data collection platform called Patient IQ. The group is part of the JUPITER study which is the largest, multicenter study ever assembled in patellofemoral instability. They are additionally planning to enroll in FDA-approved clinical studies investigating pioneering strategies for knee cartilage restoration, joint preservation, and orthobiologic injections for osteoarthritis. Recent clinical publications explore outcomes in meniscus preservation and transplantation, medial patellofemoral ligament reconstruction, osteochondral allograft and matrix-induced autologous chondrocyte implantation (MACI), and surgical augmentation using PRP/BMAC. The clinical research team actively reports results of non-surgical and surgical interventions to continue to introduce new knowledge to the field, with the goal of improved patient outcome. -
Bansari Sureshchandra Sheth
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Sheth is originally from southern California, but has progressively moved up the coast over the last few years, now making the Bay Area her wonderful new home. Board certified in Family Medicine, she had comprehensive training during residency. She has a variety of special interests, including pediatric illnesses, women’s health, diabetes care including lifestyle management, as well as Hepatitis C treatment. She believes in empowering her patients, working together with them as a team. In her free time, Dr. Sheth enjoys yoga, going to plays or musicals, comedy shows, and hiking.
-
Kunj Sheth
Assistant Professor of Urology
BioDr. Kunj Sheth is a pediatric urologist who focuses on minimally-invasive approaches to children’s surgery and treatment of complex patients. She is currently in the Biodesign Faculty Fellows Program. Her research focuses on the design and development of health technology specifically for children. She is also working to improve surgical education for residents through 3-dimensional modeling for minimally-invasive surgery. She is a part of the UCSF-Stanford Pediatric Device Consortium. Kunj graduated from Northwestern University with an undergraduate degree in biomedical engineering. She attended Northwestern University Feinberg School of Medicine and completed a Urology residency training program at the University of Texas Southwestern Medical Center. She then completed a fellowship in Pediatric Urology at Baylor College of Medicine - Texas Children's Hospital.
-
Vipul Sheth, MD, PhD
Assistant Professor of Radiology (Body MRI)
Current Research and Scholarly InterestsMy interests are in the development and translation of imaging technologies geared toward disease detection and characterization to better guide prognosis, treatment, and improve outcomes. I’m interested in supporting the development of MRI guided focal therapy methods which can personalize treatment and reduce the risk of morbidity from more invasive therapies.
Clinical Interests
- MRI for diagnosis of pelvic floor disorders
- MRI and PET/MRI to pelvic malignancies and lymph node staging.
- Whole Body MRI
- MRI guided procedures including biopsies, cryoablation, and high intensity focused ultrasound.
Translational Research Interests
- Development and translation of magnetic resonance imaging technologies to improve both diagnostics and therapeutics
- Molecular imaging and characterization of the tumor microenvironment
- Ultrashort echo time MRI applications in the body
- Developing synergistic MRI methods to complement PET in potential applications for PET/MRI -
Run Zhang Shi
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsClinical chemistry and therapeutic drug monitoring;
adult and pediatric clinical endocrine testing;
screening, detection and follow up of multiple myeloma;
tumor markers;
clinical utility of tandem mass spectrometry and high resolution mass spectrometry. -
Vivian Shih, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Vivian Shih received her Bachelor of Science with honors and Doctor of Medicine degree from the University of Miami. In 2002, she completed her postgraduate medical training in Physical Medicine and Rehabilitation at the Feinberg School of Medicine at Northwestern University and the Rehabilitation Institute of Chicago (Shirley Ryan Ability Lab). She is board certified in Physical Medicine and Rehabilitation (PM&R or Physiatry) and specializes in non-surgical management of musculoskeletal disorders, arthritis, gait and balance disorders. She also performs electrodiagnostic testing (EMG/NCS), ultrasound guided joint/soft tissue injections, and platelet rich plasma (PRP) injections. Dr. Shih previously practiced in the New Haven area from 2005 to 2018. She was an Attending Physician at Yale-New Haven Hospital and on faculty at the Yale School of Medicine. Prior to that, she had been practicing at Northwestern University Medical Center and the Rehabilitation Institute of Chicago. She has published in the Arthritis and Rheumatism journal, Academy of Physical Medicine & Rehabilitation (AAPM&R) online review, Archives of Physical Medicine and Rehabilitation journal, and Koopman's Arthritis and Allied Health textbook. She is a member of the AAPM&R, Association of Academic Physiatrists (AAP), and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM).
-
Hiroyuki Shimada
Professor of Pathology and of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Jade Shorter, MD, MSHP
Clinical Assistant Professor, Obstetrics & Gynecology
BioDr. Shorter specializes in complex family planning, early pregnancy management, and general gynecology. She is committed to improving the continuity of care for patients with early pregnancy complications and serves as the Director of the Early Pregnancy Assessment Program. Her clinical research interests include improving patients’ experience with abortion and early pregnancy care, addressing reproductive health disparities, and promoting health equity.
-
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Joseph Shrager
Professor of Cardiothoracic Surgery
Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, diaphragm plication, and surgical treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation. -
Aimee D. Shu
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioI am an endocrinologist with particular interests in reproductive and bone health.
I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.
As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.
I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.
Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City). -
Yasuhiro Shudo, MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Shudo is a board-certified cardiothoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support (MCS), and extracorporeal membrane oxygenation (ECMO). He has published numerous landmark papers
and chapters.
Dr. Shudo also performs mitral valve repair/replacement (MVR), aortic valve replacement (AVR), complex valve surgery, coronary artery bypass graft (CABG) surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement (TAVR).
Dr. Shudo is fully committed to innovative, comprehensive, and compassionate care for each patient he treats. -
Ann Shue, MD
Clinical Assistant Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBio**Dr. Shue is taking new patients for glaucoma, cataracts, and adult strabismus.**
Ann Shue, MD, is a Clinical Assistant Professor of Ophthalmology at Stanford University School of Medicine, where she specializes in glaucoma, pediatric ophthalmology, and adult strabismus, a unique combination of subspecializations practiced by few surgeons worldwide. She is a board-certified ophthalmologist who completed fellowships in glaucoma at Yale University and pediatric ophthalmology and adult strabismus at Duke University. She practices at the Stanford Byers Eye Institute and the Lucile Packard Children's Hospital.
Dr. Shue loves seeing patients of all ages with eye problems big or small, including glaucoma due to any reason, glaucoma suspicion, family history of glaucoma, cataracts, strabismus (eye misalignment) or double vision from any cause, including after eye surgeries. She completed her ophthalmology residency at the University of Pittsburgh and an internal medicine internship at UCSF Fresno. She holds a medical degree from University of California, Irvine and an undergraduate degree in biology from Yale University.
Dr. Shue is a member of the American Glaucoma Society, the American Association for Pediatric Ophthalmology and Strabismus, and the UK Paediatric Glaucoma Society. She is active in presenting at regional and national conferences. She is the author of several journal articles and recently wrote two textbook chapters on pediatric glaucoma and pediatric glaucoma surgery. -
Lawrence Shuer, MD
Professor of Neurosurgery
Current Research and Scholarly InterestsI have clinical research interests in the surgical treatment of epilepsy. I am also interested in new developments in the treatment of craniosynostosis a congenital abnormality of infant's skulls
-
Takudzwa Shumba
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Takudzwa Shumba is a family medicine clinician-educator with particular interests in global health equity, preventative medicine, women's health, pediatrics and integrative medicine. She was born and raised in Zimbabwe. Prior to beginning medical school at Stanford, she completed a Master's in Public Health at Yale, with a focus in global health. She has been involved in public health projects in Zimbabwe, Hong Kong and mainland China and Kenya. She completed her residency at Stanford Health Care - O'Connor Hospital Family Medicine in San Jose, prior to joining faculty at Stanford Family Medicine. LGBTQQI friendly. After several years as a continuity primary care provider at Stanford Family Medicine, she transitioned to providing quality same day access for acute patient needs.
She is currently Co-director of the Leadership Education in Advancing Diversity (LEAD) program, Associate Director of the Clinical Summer Internship (CSI), Course Director of the undergraduate seminar “Decolonizing Global Health,” and Co-Director of the "Social and Environmental Determinants of Health" elective. She is a California Health Care Foundation (CHCF) Fellow (2020-2022) and Presidential Leadership Scholar (2022). She previously served as the Primary Care and Population Health (PCPH) Division Global Health faculty lead and PCPH DEI faculty lead. -
Anjali Sibley MD, MPH
Clinical Associate Professor, Medicine - Oncology
BioDr. Sibley is a Clinical Associate Professor of Medicine (Oncology) at Stanford School of Medicine. She is the Director of the Stanford Medicine Cancer Center in Emeryville and is a board-certified, fellowship-trained hematologist and medical oncologist.
Her clinical interests include treating solid tumor cancers, lung cancers, blood cancers and benign blood conditions. She is interested in cancer prevention and reducing disparities in hematologic/oncologic care among underserved populations, and successful cancer survivorship programs.
In addition to responsibilities related to patient care and overseeing the Cancer Center in Emeryville, Dr. Sibley has developed and is leading an innovative cancer survivorship clinic, including an exercise initiative. She also is passionate about advancing clinical trial enrollment for medically underserved populations and she serves on the Cancer Network’s East Bay Health Equity Committee leading lung cancer screening efforts in the East Bay. She is also working on a Stanford Cancer Institute-funded study examining psychosocial factors and cardiac health in Black cancer patients in the East Bay.
She believes that providing patient care is a true privilege. Dr. Sibley utilizes a patient-centered practice approach that addresses multiple aspects of a patient’s well-being. Her research interests have included chemoprevention of breast cancer and the development of magnetic resonance imaging technology in breast cancer detection and mapping. She has also led community-based efforts to implement low-dose computed tomography (LDCT) as a screening tool for cancer.
Dr. Sibley’s publications include articles on breast cancer prevention, breast magnetic resonance imaging, and other topics. Her work has appeared in American Journal of Hematology, JAMA, the Breast Journal, Internal Medicine News, and elsewhere. Dr. Sibley was invited to deliver a peer-reviewed presentation on community-based cancer screening and preventive education to the Global Health Council. Dr. Sibley is on the board of directors of the Cancer Support Community SF Bay Area. She has also served as a clinic physician for the Native American Health Center of Oakland, on the Committee on Health Equity of the American Public Health Association, and as chair and vice chair of the Cancer Forum Caucus of the American Public Health Association. She is a member of the American Society of Clinical Oncology, American Society of Preventive Oncology, and American Society of Hematology. She has provided volunteer services to the Global Health Council and to the Cancer Patients Aid Association, for whom she conducted a patient screening and education program in Mumbai, India. -
Eric Sibley, M.D., Ph.D.
Professor of Pediatrics (Gastroenterology)
Current Research and Scholarly InterestsMolecular Regulation of Intestinal Development and Maturation. We study transcriptional mechanisms regulating the spatial and temporal restriction of intestine-specific gene expression during gut development. Our approach is to characterize the function of gene-specific DNA cis elements and interacting nuclear proteins in cell culture and in transgenic animals. The goal is to relate the gene-specific control mechanisms to the broader pathways specifying acquisition of gut phenotypes.
-
Richard Sibley
Professor of Pathology, Emeritus
Current Research and Scholarly InterestsImmunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders.
-
Surbhi Sidana, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Sidana is a hematologist/oncologist who is fellowship trained in advanced hematology with an emphasis on myeloma, amyloidosis, and dysproteinemia disorders. She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine. She leads the Myeloma Cellular Immunotherapy program at Stanford.
Her areas of expertise include transplantation and novel cellular immunotherapies such as CAR-T-cell therapy for patients with multiple myeloma. For each patient, Dr. Sidana develops a personalized care plan designed to optimize outcomes and quality of life.
Dr. Sidana conducts extensive research. Currently, she is conducting clinical trials of CAR-T therapy and bispecific T-cell engagers for treatment of patients with myeloma. She is studying patients’ access to CAR-T cell therapy, the financial burden of the treatment, and its impact on patients’ quality of life and cognitive function.
Dr Sidana has received a grant from the Stanford Medicine Cancer Institute and NIH funding through the Stanford KL2 program to study adverse events of CAR-T therapy on patients and monitoring of patients undergoing CAR-T therapy using wearable devices.
In the past, Dr. Sidana received Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research on the impact of clinical trial participation on patients with multiple myeloma and lymphoma. She has also received grants from the Amyloidosis Foundation and International Waldenstrom’s Macrogloulinemia Foundation to understand AL amyloidosis, a rare disease caused by buildup of an abnormal protein.
Dr. Sidana has given presentations at regional and national conferences and her work has been published in high-impact journals.
Dr. Sidana has been recognized for her work with many honors, including an Outstanding Hematology/Oncology Fellow award and Outstanding Research Fellow award from the Mayo Clinic.
She is a member of the American Society of Hematology, American Society of Clinical Oncology, International Myeloma Society, International Society of Amyloidosis, and American Society of Transplantation & Cellular Therapy. Dr. Sidana is often an invited speaker at patient support groups as well as symposia and workshops for her peers. -
Douglas Sidell, MD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Sidell's clinical interests include the management of children with voice and swallowing disorders, and congenital or acquired airway abnormalities. Examples of ongoing or upcoming prospective trials include an investigation into the utility of acid suppression in children with laryngomalacia, the management of vocal cord paralysis following cardiac surgery, and the management of type 1 laryngeal clefts in children.
-
Arend Sidow
Professor of Pathology and of Genetics
On Leave from 04/01/2024 To 02/21/2025Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.
More information can be found here: http://www.sidowlab.org -
Allison Tamara Siebern
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Allison Siebern, PhD, DAc, LAc, CBSM is a sleep medicine psychologist and neuroscience-based doctor of acupuncture specializing in sleep, mood, and neurological health. She is board certified in Behavioral Sleep Medicine by the American Board of Sleep Medicine.
Dr. Siebern is a pioneer in the field of integrative sleep health as she blends her training and expertise in neuroscience-based acupuncture, cognitive behavioral medicine, psychophysiology, near-infrared transcranial photobiomodulation and clinical neuroscience. Dr. Siebern's current integrative health research is on the intersection of scalp acupuncture and near-infrared transcranial photobiomodulation (tPBM) as neuromodulatory mechanisms to assist in improved symptom outcomes in neurodegenerative disorders and post-stroke recovery.
Dr. Siebern is currently a Sleep Medicine Psychologist and Behavioral Sleep Medicine Fellowship Track Director with the Durham VA Medical Center and the Director of Integrative Sleep Wake Health, PLLC. Dr. Siebern is an Adjunct Clinical Associate Professor at Stanford University School of Medicine in the Sleep Medicine Division where she completed the sleep fellowship from 2008 to 2010 and stayed on as full-time faculty until 2015 where she served as Associate Director and Co-Fellowship Training Director and then Director of the Behavioral Sleep Medicine Program. She has been treating patients of all ages in the field of sleep medicine for 15 years. She consults with companies on sleep and neurological health science, is published in peer-reviewed journals, has given talks at national conferences, and has been interviewed with many media outlets. Dr. Siebern has a passion for the field of sleep health and believes in the importance of training future generations of sleep providers. -
Dawn H. Siegel, MD
Clinical Professor, Dermatology
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsI'm dedicated to connecting patients with clinical research trials and contributing to research on specific skin conditions particularly hemangiomas, birthmarks, and PHACE syndrome. My research also aims to develop solutions to health disparities through improved access to pediatric dermatologists and treatments.
-
Robert Siegel
Professor (Teaching) of Microbiology and Immunology
Current Research and Scholarly InterestsMy work is primarily involved in medical education and curricular development, especially in the areas of infectious disease, virology, HIV, and molecular biology. Projects included electronic applications to science education, three dimensional model building, service learning, and the development of undergraduate research projects.
-
Branimir I. Sikic, M. D.
Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsResearch Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, CD47 as a target for activation of anticancer macrophases, Phase I trials of new drugs, gene expression profiling of cancers
-
Oscar Silva
Clinical Assistant Professor, Pathology
BioOscar is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from UCLA. His interests include immunology, the pathogenesis and diagnosis of lymphomas, and global health.
-
Ruwan Silva, MD, MPhil
Clinical Assistant Professor, Ophthalmology
BioProfessor Ruwan Amila Silva, MD, MPhil is board certified and fellowship trained vitreoretinal surgeon in the department of ophthalmology at Stanford University Medical Center. He received his BA in Neurobiology from Harvard University graduating Magna cum laude with Highest Honors. He then received his Masters of Philosophy (MPhil) in Neurobiology from Cambridge University in England. Following this, he received his medical degree from Stanford University’s School of Medicine. Dr. Silva completed his ophthalmology residency at the Bascom Palmer Eye Institute, the top rated eye hospital in the country. While there he was awarded the Heed Fellowship, the most prestigious national award for ophthalmology residents in the country. Dr. Silva returned to Stanford University to complete his vitreoretinal surgery fellowship where he was awarded the Ronald G. Michels Foundation Award, the nation’s highest honor for a retina surgery fellow. During his fellowship at Stanford he was also awarded the prestigious Evangelos S. Gragoudas Award by the Macula Society. Following fellowship, Dr. Silva remained at Stanford University's School of Medicine as an Assistant Professor of Vitreoretinal Surgery in the Department of Ophthalmology. Since 2015, he has been named one of “America’s Top Ophthalmologists” by Consumers’ Research Council of America. He was also selected as a "Top Ophthalmologist" by the International Association of Ophthalmologists.
Dr. Silva's clinical practice focuses mainly on macular degeneration and retinal vascular disease (such as diabetic retinopathy, retinal vein occlusions and central serous retinopathy). Surgically, he specializes in diseases of the vitreous and retina: including repair of retinal detachments, surgery for the macula (such as treatment of epiretinal membranes and macular holes) and correction of dislocated intraocular lenses. His research interests mainly involve developing novel therapies for these diseases (http://med.stanford.edu/artificial-retina.html) and have resulted in over 50 combined peer-reviewed scientific manuscripts, book chapters and national meeting presentations.
Dr. Silva is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, as well as the American Society of Retina Specialists. He is a Board Certified Diplomate of the American Board of Ophthalmology. -
Gerald Silverberg
Professor of Neurosurgery, Emeritus
Current Research and Scholarly InterestsAge-related changes in the blood-brain barrier (BBB)and on CSF dynsmics decrease the clearance of toxic metabolites, such as amyloid beta peptides (A-betas), from the brain. I am studing the effects of aging and hydrocephalus on the BBB receptors that transport A-betas and on the formation and bulk flow of CSF.
-
Norman H. Silverman
Honorary Faculty Emeritus, Pediatrics
Current Research and Scholarly InterestsMy research interests center around cardiac ultrasound. I am currently working on several areas in the development of human cardiac ultrasound.
These are fetal cardiac ultrasound. intraoperative and transesophageal ultrasound imaging in children, imaging potiential for ultrasound two and three dimensional modalities in children with congenital heart disease -
Julia Fridman Simard
Associate Professor of Epidemiology and Population Health, of Medicine (Immunology & Rheumatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)
BioJulia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and, by courtesy, of Medicine in Immunology and Rheumatology and Obstetrics and Gynecology in Maternal Fetal Medicine at Stanford University School of Medicine.
Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.
While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford’s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.
In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus. -
Robert Simoni
Professor, Biology
Current Research and Scholarly InterestsCholesterol in biological membranes; genetic mechanisms & cholesterol production
-
Laura Simons
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
Current Research and Scholarly InterestsI am a Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine and a clinical psychologist who evaluates and treats youth presenting with chronic pain in the Pediatric Pain Management Clinic (PPMC) at Stanford Children’s Health. My program of research aims to utilize a pain neuroscience psychology approach to gain a mechanistic understanding of cognitive and affective processes in pediatric pain, perform rigorous patient-oriented research that translates targeted assessment into mechanistically informed treatment approaches for optimal clinical care and leverage the ubiquity of digital health to enhance patient access and reach. Central to these goals are projects targeting adolescence and youth adults with chronic pain that encompass defining brain signatures of threat interpretation, evaluating the efficacy of graded exposure (NCT03699007), deriving a biosignature of improvement vs. persistence of pain and disability (NCT04285112), and evaluating the impact of virtual reality on pain rehabilitation (NCT04636177). These studies along with additional work examining the journey of pain care for youth with pain and their parents form a comprehensive research portfolio in the realm of understanding and treating chronic pain in young people. My long-term career goal is to lead a robust research program focusing on alleviating the suffering of youth and emerging adults with chronic pain.
-
Bob Sinclair
Charles M. Pigott Professor in the School of Engineering
BioUsing high-resolution transmission electron microscopy, Sinclair studies microelectronic and magnetic thin film microstructure.
